Search

everythinglearnresearchcommunity

for

Search:↓

Hodgkin's lymphoma can show up as hair loss.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

CHOP chemotherapy for non-Hodgkin's lymphoma commonly causes hair loss, fatigue, taste changes, and nausea.

Using hair dye may slightly increase the risk of non-Hodgkin's lymphoma, especially with long-term use.

A woman's small, unnoticed adrenal mass turned out to be a rare non-Hodgkin's lymphoma, treated successfully with surgery and therapy.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

An elderly woman's swollen, painful foot was found to be caused by a rare type of bone lymphoma, which improved with radiation treatment.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Hair loss may be an early sign of serious illnesses like Hodgkin disease.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.